0.91Open1.30Pre Close239 Volume1.46K Open Interest80.00Strike Price17.04KTurnover43.28%IV1.74%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.2786Delta0.1906Gamma263.10Leverage Ratio-0.3122Theta0.0006Rho73.30Eff Leverage0.0137Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet